Cholesterol-related Gene Variants Are Associated with Diabetes in Coronary Artery Disease Patients

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2021 May 22

PMID 34021444

Citations 1

Authors

Aybike Sena Ozuynuk

Aycan Fahri Erkan

Berkay Ekici

Nihan Erginel-Unaltuna

Neslihan Coban

Affiliations

Soon will be listed here.

Abstract

Coronary artery disease (CAD) which is a complex cardiovascular disease is the leading cause of death worldwide. The changing prevalence of the disease in different ethnic groups pointing out the genetic background of CAD. In this study, we aimed to evaluate the contribution of selected cholesterol metabolism-related gene polymorphisms to CAD presence. A total of 493 individuals who underwent coronary angiography were divided into 2 groups: normal coronary arteries (≤ 30% stenosis) and critical disease (≥ 50% stenosis). Individuals were genotyped for APOC1 (rs11568822), APOD (rs1568565), LIPA (rs13500), SORL1 (rs2282649), and LDLR (rs5930) polymorphisms using hydrolysis probes in Real-Time PCR. Blood samples were drawn before coronary angiography and biochemical analyses were done. The results were statistically evaluated. When the study group was stratified according to CAD, the minor allele of APOD polymorphism was found related to decreased risk for T2DM in the non-CAD group. In logistic regression analysis adjusted for several confounders, LDLR rs5930 polymorphism was found associated with T2DM presence in the male CAD group [OR = 0.502, 95%CI (0.259-0.974), p = 0.042]. Besides, APOD and LIPA polymorphisms were shown to affect serum lipid levels in non-CAD T2DM patients (p < 0.05). The minor allele of APOC1 was found associated with triglyceride levels in males independent of CAD status. Besides, LDLR minor allele carrier females had elevated HbA1c and glucose levels independent from CAD status in the whole group. The cholesterol metabolism-related gene polymorphisms were found associated with T2DM and biochemical parameters stratified to sex, CAD, and T2DM status.

Citing Articles

Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review.

Rouland A, Masson D, Lagrost L, Verges B, Gautier T, Bouillet B Cardiovasc Diabetol. 2022; 21(1):272.

PMID: 36471375 PMC: 9724408. DOI: 10.1186/s12933-022-01703-5.

References

Mozaffarian D, Benjamin E, Go A, Arnett D, Blaha M, Cushman M . Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016; 133(4):447-54. DOI: 10.1161/CIR.0000000000000366. View

Malakar A, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S . A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019; 234(10):16812-16823. DOI: 10.1002/jcp.28350. View

Lusis A . Atherosclerosis. Nature. 2000; 407(6801):233-41. PMC: 2826222. DOI: 10.1038/35025203. View

Navarro-Incio A, Tolivia-Fernandez J . [The involvement of apolipoprotein D in pathologies affecting the nervous system]. Rev Neurol. 2004; 38(12):1166-75. View

Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L . Apolipoprotein D. Biochim Biophys Acta. 2000; 1482(1-2):185-98. DOI: 10.1016/s0167-4838(00)00162-x. View

Jong M, Hofker M, Havekes L . Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol. 1999; 19(3):472-84. DOI: 10.1161/01.atv.19.3.472. View

McPherson A, Larson S . The structure of human apolipoprotein C-1 in four different crystal forms. J Lipid Res. 2018; 60(2):400-411. PMC: 6358290. DOI: 10.1194/jlr.M089441. View

Ference B, Ginsberg H, Graham I, Ray K, Packard C, Bruckert E . Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017; 38(32):2459-2472. PMC: 5837225. DOI: 10.1093/eurheartj/ehx144. View

Catapano A, Graham I, De Backer G, Wiklund O, Chapman M, Drexel H . 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016; 37(39):2999-3058. DOI: 10.1093/eurheartj/ehw272. View

10.

Jiang M, Bujo H, Ohwaki K, Unoki H, Yamazaki H, Kanaki T . Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. J Clin Invest. 2008; 118(8):2733-46. PMC: 2447934. DOI: 10.1172/JCI32381. View

11.

Suwa S, Ogita M, Takahashi N, Wada H, Dohi T, Kasai T . Impact of LR11 as Residual Risk on Long-Term Clinical Outcomes in Patients with Coronary Artery Disease Treated with Statins after First Percutaneous Coronary Intervention. Int Heart J. 2020; 61(3):470-475. DOI: 10.1536/ihj.19-686. View

12.

Dubland J, Francis G . Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism. Front Cell Dev Biol. 2015; 3:3. PMC: 4313778. DOI: 10.3389/fcell.2015.00003. View

13.

Du H, Schiavi S, Wan N, Levine M, Witte D, Grabowski G . Reduction of atherosclerotic plaques by lysosomal acid lipase supplementation. Arterioscler Thromb Vasc Biol. 2003; 24(1):147-54. DOI: 10.1161/01.ATV.0000107030.22053.1e. View

14.

Gensini G . A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983; 51(3):606. DOI: 10.1016/s0002-9149(83)80105-2. View

15.

Serruys P, Morice M, Kappetein A, Colombo A, Holmes D, Mack M . Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360(10):961-72. DOI: 10.1056/NEJMoa0804626. View

16.

Miller S, Dykes D, Polesky H . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. PMC: 334765. DOI: 10.1093/nar/16.3.1215. View

17.

Jamaldini S, Babanejad M, Mozaffari R, Nikzat N, Jalalvand K, Badiei A . Association of polymorphisms at LDLR locus with coronary artery disease independently from lipid profile. Acta Med Iran. 2014; 52(5):352-9. View

18.

Jha C, Mir R, Banu S, Elfaki I, Chahal S . Heterozygosity in LDLR rs2228671 and rs72658855 Gene is Associated with Increased Risk of Developing Coronary Artery Disease in India -A Case-Control Study. Endocr Metab Immune Disord Drug Targets. 2019; 20(3):388-399. DOI: 10.2174/1871530319666191015164505. View

19.

Salazar L, Hirata M, GIANNINI S, Forti N, Diament J, Lima T . Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clin Chim Acta. 2000; 300(1-2):139-49. DOI: 10.1016/s0009-8981(00)00308-9. View

20.

Guven G, Vurgun E, Bilgic B, Hanagasi H, Gurvit H, Ozer E . Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort. Mol Biol Rep. 2019; 46(2):1701-1707. DOI: 10.1007/s11033-019-04619-8. View